Case number 1:18-cv-00132
Onyx Therapeutics, Inc. v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (26) |
| May 8, 2019 | 16 | Order (3) Docket Text: CONSENT JUDGMENT as to Apotex, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/7/19. Associated Cases: 1:16-cv-01039-LPS, 1:17-cv-01202-LPS, 1:18-cv-00132-LPS (ntl) |
| May 4, 2019 | 15 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT Between Onyx Therapeutics, Inc. and Apotex Inc. & Apotex Corp. by Onyx Therapeutics, Inc.. (Dellinger, Megan) |
| Jul 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] Stipulation and Order Regarding Consolidation filed by Onyx Therapeutics, Inc. Signed by Judge Leonard P. Stark on 7/12/18. (ntl) |
| Jul 13, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:16-cv-00988-LPS. (ntl) |
| Jul 10, 2018 | 14 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Consolidation by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Jun 26, 2018 | N/A | Order (0) |
| Mar 9, 2018 | 12 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by Apotex Corp., Apotex Inc..(Bellew, Joseph) |
| Feb 26, 2018 | N/A | SO ORDERED (0) |
| Feb 26, 2018 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and Affirmative Defenses by Apotex Corp., Apotex Inc..(Bellew, Joseph) |
| Feb 26, 2018 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Bellew, Joseph) |
| Feb 23, 2018 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants to Move, Answer or Otherwise Respond to Plaintiff's Complaint to February 26, 2018 - filed by Apotex Corp., Apotex Inc.. (Bellew, Joseph) |
| Feb 22, 2018 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Joseph James Bellew on behalf of Apotex Corp., Apotex Inc. (Bellew, Joseph) |
| Jan 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Jan 26, 2018 | 7 | Declaration (7) Docket Text: DECLARATION of Mailing on Apotex Inc. by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Jan 25, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 1/25/2018; Apotex Inc. on 1/25/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
| Jan 25, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Onyx Therapeutics, Inc.. Apotex Corp. served on 1/25/2018, answer due 2/15/2018. (Noreika, Maryellen) |
| Jan 24, 2018 | 1 | Exhibits A-I (343) |
| Jan 24, 2018 | 1 | Civil Cover Sheet (3) |
| Jan 24, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Jan 24, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/14/2017. Date of Expiration of Patent: See form.Thirty Month Stay Deadline: 6/14/2020. (fms) |
| Jan 24, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,417,042 B2; 7,232,818 B2; 7,491,704 B2; 7,737,112 B2; 8,129,346 B2; 8,207,125 B2; 8,207,126 B2; 8,207,127 B2; 8,207,297 B2. (fms) |
| Jan 24, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc., Corporate Parent Onyx Pharmaceuticals, Inc. for Onyx Therapeutics, Inc. filed by Onyx Therapeutics, Inc. (fms) |
| Jan 24, 2018 | 1 | Main Document (26) Docket Text: COMPLAINT For Patent Infringement filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2308330.) - filed by Onyx Therapeutics, Inc. (Attachments: # (1) Exhibits A-I, # (2) Civil Cover Sheet)(fms) |
| Jan 24, 2018 | 1 | Complaint* (1) |
